| Outcome Measures: |
Primary: Serum creatinine values in pre-specified periods, Delta and area under curve, Pre PCI|Serum creatinine values in pre-specified periods, Delta and area under curve, Day 1|Serum creatinine values in pre-specified periods, Delta and area under curve, Day 2|Serum creatinine values in pre-specified periods, Delta and area under curve, Day 30|NGAL values in pre-specified periods, Delta and area under curve, Pre PCI|NGAL values in pre-specified periods, Delta and area under curve, Day 1|NGAL values in pre-specified periods, Delta and area under curve, Day 2|NGAL values in pre-specified periods, Delta and area under curve, Day 30 | Secondary: Increase in serum creatinine ≥ 0.3 mg/dl or 50% from the baseline value, within 48 hours after the index procedure, CI-AKI will be defined as an increase in serum creatinine ≥ 0.3 mg/dl or 50% from the baseline value, within 48 hours after the index procedure CI-AKI will be defined as an increase in serum creatinine ≥ 0.3 mg/dl or 50% from the baseline value, within 48 hours after the index procedure, 48 hours after PCI|Biomarkers elevation ≥10 upper reference limit (URL) for creatine kinase MB (CKMB) and/or ≥70 URL for troponin, Periprocedural MI will be defined as biomarkers elevation ≥10 upper reference limit (URL) for creatine kinase MB (CKMB) and/or ≥70 URL for troponin, 24 hours after PCI|Occurrence of definite or probable stent thrombosis, Stent thrombosis will be defined as the occurrence of definite or probable stent thrombosis according to the Academic Research Consortium (ARC) criteria, Until 30 days|Death From Cardiovascular Causes, Secondary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, definite or probable stent thrombosis, stroke, bleeding (BARC 3-5) or death, Until 30 days|Myocardial Infarction, Secondary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, definite or probable stent thrombosis, stroke, bleeding (BARC 3-5) or death, Until 30 days|Hospitalization for Unstable Angina, Secondary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, definite or probable stent thrombosis, stroke, bleeding (BARC 3-5) or death, Until 30 days|Stroke, Secondary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, definite or probable stent thrombosis, stroke, bleeding (BARC 3-5) or death, Until 30 days|Bleeding (BARC 3-5), Secondary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, definite or probable stent thrombosis, stroke, bleeding (BARC 3-5) or death, Until 30 days|Death, Secondary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, definite or probable stent thrombosis, stroke, bleeding (BARC 3-5) or death, Until 30 days
|
